Ocular Therapeutix (OCUL) Tops Q3 EPS by 4c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $15.08 million versus the consensus estimate of $15.23 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion